Skyscape Web Viewer : Evidenced-Based Medicine Guidelines (EBMG) : Main Index

View All
Alpha-2 adrenergic agonists
Alpha-adrenergic agonists
Alpha blockers
Alpha-blockers
N06AA02
N06AA04
N06AA06
N06AA07
N06AA09
N06AA10
N06AA12
N06AA21
N06AB03
N06AB04
N06AB05
N06AB06
N06AB08
N06AB10
N06AG02 Anxiety Disorder Hypertension: Investigations, Treatment Initiation and Non-Pharmacological Treatment Pharmacological Treatment of Depression Psychopharmacotherapy in Children and Adolescents
N06AX03 Direct Oral Anticoagulants Functional Bowel Disorders and the Irritable Bowel Syndrome (IBS) Long-Term Benzodiazepine Use and Withdrawal Pharmacological Treatment of Depression Psychosocial Support for Patients with Cancer
N06AX05 Direct Oral Anticoagulants Insomnia Pharmacological Treatment of Depression
N06AX11
N06AX12 Acute Coronary Syndrome Depression in the Elderly Direct Oral Anticoagulants Multiple Sclerosis (Ms) Pharmacological Treatment of Depression Smoking Cessation
N06AX14 Direct Oral Anticoagulants Pharmacological Treatment of Depression
N06AX16
N06AX17 Anxiety Disorder Chronic Pain Direct Oral Anticoagulants Fatigue Fibromyalgia Multiple Sclerosis (Ms) Pharmacological Treatment of Depression
N06AX18 Direct Oral Anticoagulants Multiple Sclerosis (Ms) Pharmacological Treatment of Depression
N06AX21
N06AX22 Depression in the Elderly Direct Oral Anticoagulants Pharmacological Treatment of Depression
N06AX25 Direct Oral Anticoagulants Pharmacological Treatment of Depression